Tobi Jesse turned 4 years old on Christmas Eve. He lives with autism and a rare, progressive neuromuscular disease called ...

Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the ...

Acosta Group and the MDA are celebrating 40 years of collaboration, raising more than $102 million in support of research, ...

The next evolution of truFlex fortifies its position as a versatile solution for rehabilitation with new applications in functional strength for the abdomen, arms, calves, glutes and thighs.

Jake Schneider, an ALS patient, was able to reconnect with the world through Neuralink, a brain-computer interface device ...

Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, ...

Findings from two clinical trials suggest Novartis' Itvisma is safe and effective for SMA patients over 2 years old.

What Happened: Harper's recent Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday unveiled the sale of 26,746 shares of Catalyst Pharmaceuticals. The total transaction value is ...

A weak core could increase your risk of lower-body injuries and keep athletes on the sidelines. Let’s explore the research.

For nearly a decade, Solid has been a staunch supporter and a steering committee member of Parent Project Muscular Dystrophy’s (PPMD) committee dedicated to implementing newborn screening for Duchenne ...

A new peer-reviewed study published in Frontiers in Sports and Active Living found that while female athletes weren’t more ...

Cure Rare Disease (CRD) announced it has been awarded a $7.4 million grant from the California Institute for Regenerative Medicine (CIRM) to advance the development of a novel gene therapy for ...